Alteogen Inc. (South Korea)

Alteogen Inc. is a bio company located in Daejeon, South Korea. Founded in 2008, the company specializes in next-generation biologics. Their portfolio includes biobetters with improved efficacy compared to existing biologics, biosimilars that demonstrate comparability to existing biologics, and proprietary biologics. Alteogen focuses on three cutting-edge areas of the industry: long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars with complexity. They have developed NexP Fusion Technology, a next-generation long-acting biobetter technology, NexMab ADC Technology, an Antibody-Drug Conjugate technology, and a novel human hyaluronidase PH 20 based on Hybrozyme Technology. Additionally, Alteogen is involved in joint development of Antibody Biosimilars with overseas strategic alliance partners.